The domestic box office is poised for its biggest Thanksgiving haul since the pandemic thanks to a Polynesian princess, a pair of witches and a revenge-fueled gladiator.Disney's "Moana 2" is set to hit theaters Wednesday and generate between $120 million and $150 million in box office receipts in the U.S. and Canada through Sunday. It'll be joined by Universal's "Wicked" and Paramount's "Gladiator II," both in their second week of domestic screenings.Box office analysts believe the five-day Thanksgiving wee ...

Designation underscores significant unmet need in frontotemporal dementia and the potential role of neflamapimod in multiple neurologic disorders On track to report topline data from the RewinD-LB Phase 2b clinical trial in early-stage dementia with Lewy bodies (DLB) in December 2024 BOSTON, Nov. 27, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company focused on developing treatments for age-related neurologic disorders, today announced that its oral investigational drug neflamap ...

TORONTO, Nov. 27, 2024 /PRNewswire/ - Denison Mines Corp. ("Denison" or the "Company") (TSX: DML) (NYSE American: DNN) is pleased to announce that is has executed an agreement (the "Agreement") with Cosa Resources Corp. ("Cosa") (TSX-V: COSA) to form three uranium exploration joint ventures in the eastern portion of the Athabasca Basin region in northern Saskatchewan. Pursuant to the Agreement, Cosa will acquire a 70% interest in Denison's 100%-owned Murphy Lake North, Darby, and Packrat properties (the "Pr ...

Broad method of use patent protection for COM902, a potential best-in-class reduced Fc, clinical stage, anti-TIGIT antibody, in triple combination with any anti-PD-1 antibody and any anti-PVRIG antibody for the treatment of cancer Further strengthens Compugen's IP portfolio across DNAM-1 axis checkpoint inhibitorsHOLON, Israel, Nov. 27, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announce ...

TEL AVIV, Israel, Nov. 27, 2024 /PRNewswire/ -- RADCOM LTD (NASDAQ: RDCM) announced today that Hadar Rahav, Chief Financial Officer, will participate in the Benchmark 13th Annual Discovery One-on-One Investor Conference scheduled to be held on Wednesday, December 11, 2024, in New York.Mrs. Rahav will be available on-site for one-on-one investor meetings. To schedule a meeting, please get in touch with your Benchmark representative.About RADCOMRADCOM (Nasdaq: RDCM) is the leading expert in 5G ready cloud-nat ...

PITTSBURGH, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in fireside chats and host investor meetings at two upcoming investor conferences: Citi’s 2024 Global Healthcare Conference on December 3, 2024 in Miami, Florida; fireside chat scheduled for 8:45 am ET7th Annual Evercore HealthCONx Conference on December 4, 2024 in Coral Gable ...

-Promising results obtained from the pre-clinical study with CollPlant's commercial sized rhCollagen-based regenerative breast implants, demonstrating significant implant vascularization and rapid ingrowth of native tissue-Innovative breast implant technology designed to address a $3.0 billion market opportunity-Cash and cash equivalents balance as of September 30, 2024 was $15.4 million-Conference call to be held today at 10:00 a.m. U.S. EDT –REHOVOT, Israel, Nov. 27, 2024 /PRNewswire/ -- CollPlant Biotech ...

NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced the appointment of Felicia DellaFortuna as Chief Financial Officer, effective January 1, 2025. She succeeds Heather Stark, who will remain with the Company through December 27, 2024. “We are thrilled to welcome Felicia DellaFortuna as our new Chief Financial Officer at this pivotal time for WeightWatchers,” said Tara Comonte, Interim Chief Executive Officer. “Felicia bri ...

SEATTLE, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today announced that members of its senior leadership team will participate in and be available for one-on-one meetings with investors at the following upcoming investor conferences. 36th Annual Piper Healthcare ConferenceDate: December 3, 2024Location: New York, NYFo ...

NASDAQ:EUTSXV:EUwww.encoreuranium.com DALLAS, Nov. 27, 2024 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy Company™ announces that effective January 1, 2025, its reporting status with the U.S. Securities and Exchange Commission will change from a foreign filer to a U.S. domestic filer. As a result of the change in status the Company will file its annual and quarterly reports on Form 10-K and Form 10-Q respectively, commencing with the Form 10-K ...